These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17640846)

  • 21. Evaluation of a bedside blood ketone sensor: the effects of acidosis, hyperglycaemia and acetoacetate on sensor performance.
    Khan AS; Talbot JA; Tieszen KL; Gardener EA; Gibson JM; New JP
    Diabet Med; 2004 Jul; 21(7):782-5. PubMed ID: 15209774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmortem
    Heimer J; Gascho D; Chatzaraki V; Knaute DF; Sterzik V; Martinez RM; Thali MJ; Zoelch N
    Int J Legal Med; 2018 Mar; 132(2):593-598. PubMed ID: 29170817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent binding of acetone to aminophospholipids in vitro and in vivo.
    Kuksis A; Ravandi A; Schneider M
    Ann N Y Acad Sci; 2005 Jun; 1043():417-39. PubMed ID: 16037264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitive and simplified method for the differential determination of serum levels of ketone bodies.
    Harano Y; Kosugi K; Hyosu T; Uno S; Ichikawa Y; Shigeta Y
    Clin Chim Acta; 1983 Nov; 134(3):327-36. PubMed ID: 6640949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectral evidence for the oxidation of beta-hydroxybutyrate to acetoacetate: diminution of spectra by glucose and chloride.
    Zaidi SS; Bhatnagar VK
    Indian J Biochem Biophys; 1992 Dec; 29(6):487-9. PubMed ID: 1294466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capillary electrophoretic analysis of advanced glycation endproducts formed from the reaction of reducing sugars with the amino group of glucosamine.
    Dutta U; Dain JA
    Anal Biochem; 2005 Aug; 343(2):237-43. PubMed ID: 15992760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effect of certain compounds on the lysosomal release of polymorphonuclear leukocytes.
    Chari SN; Nath N; Rathi AB
    Indian J Physiol Pharmacol; 1983; 27(3):227-33. PubMed ID: 6668054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for glucose-triggered modifications of glutathione.
    Jerić I; Horvat S
    J Pept Sci; 2009 Aug; 15(8):540-7. PubMed ID: 19579211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications.
    Saraswat M; Reddy PY; Muthenna P; Reddy GB
    Br J Nutr; 2009 Jun; 101(11):1714-21. PubMed ID: 18986599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of a high level of serum beta-hydroxybutyrate to cause of death.
    Kanetake J; Kanawaku Y; Mimasaka S; Sakai J; Hashiyada M; Nata M; Funayama M
    Leg Med (Tokyo); 2005 May; 7(3):169-74. PubMed ID: 15847825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding non-enzymatic aminophospholipid glycation and its inhibition. Polar head features affect the kinetics of Schiff base formation.
    Caldés C; Vilanova B; Adrover M; Muñoz F; Donoso J
    Bioorg Med Chem; 2011 Aug; 19(15):4536-43. PubMed ID: 21719301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood β-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review.
    Klocker AA; Phelan H; Twigg SM; Craig ME
    Diabet Med; 2013 Jul; 30(7):818-24. PubMed ID: 23330615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiglycation effect of gliclazide on in vitro AGE formation from glucose and methylglyoxal.
    Li W; Ota K; Nakamura J; Naruse K; Nakashima E; Oiso Y; Hamada Y
    Exp Biol Med (Maywood); 2008 Feb; 233(2):176-9. PubMed ID: 18222972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycation of a lysine-containing tetrapeptide by D-glucose and D-fructose--influence of different reaction conditions on the formation of Amadori/Heyns products.
    Jakas A; Katić A; Bionda N; Horvat S
    Carbohydr Res; 2008 Sep; 343(14):2475-80. PubMed ID: 18656854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
    Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
    Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions.
    Haces ML; Hernández-Fonseca K; Medina-Campos ON; Montiel T; Pedraza-Chaverri J; Massieu L
    Exp Neurol; 2008 May; 211(1):85-96. PubMed ID: 18339375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between skin acetone and blood beta-hydroxybutyrate concentrations in diabetes.
    Yamane N; Tsuda T; Nose K; Yamamoto A; Ishiguro H; Kondo T
    Clin Chim Acta; 2006 Mar; 365(1-2):325-9. PubMed ID: 16223475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketone measurements using dipstick methodology in cats with diabetes mellitus.
    Zeugswetter F; Pagitz M
    J Small Anim Pract; 2009 Jan; 50(1):4-8. PubMed ID: 19037889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.